BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22249334)

  • 21. Identification of new biomarkers of pyridoxine-dependent epilepsy by GC/MS-based urine metabolomics.
    Kuhara T; Akiyama T; Ohse M; Koike T; Shibasaki J; Imai K; Cooper AL
    Anal Biochem; 2020 Sep; 604():113739. PubMed ID: 32339489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial outcome of early dietary lysine restriction as an adjunct to pyridoxine therapy in a child with pyridoxine dependant epilepsy due to Antiquitin deficiency.
    Kava MP; Bryant L; Rowe P; Lewis B; Greed L; Balasubramaniam S
    JIMD Rep; 2020 Jul; 54(1):9-15. PubMed ID: 32685344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy.
    Gallagher RC; Van Hove JL; Scharer G; Hyland K; Plecko B; Waters PJ; Mercimek-Mahmutoglu S; Stockler-Ipsiroglu S; Salomons GS; Rosenberg EH; Struys EA; Jakobs C
    Ann Neurol; 2009 May; 65(5):550-6. PubMed ID: 19142996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene.
    Plecko B; Paul K; Paschke E; Stoeckler-Ipsiroglu S; Struys E; Jakobs C; Hartmann H; Luecke T; di Capua M; Korenke C; Hikel C; Reutershahn E; Freilinger M; Baumeister F; Bosch F; Erwa W
    Hum Mutat; 2007 Jan; 28(1):19-26. PubMed ID: 17068770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel mouse model for pyridoxine-dependent epilepsy due to antiquitin deficiency.
    Al-Shekaili HH; Petkau TL; Pena I; Lengyell TC; Verhoeven-Duif NM; Ciapaite J; Bosma M; van Faassen M; Kema IP; Horvath G; Ross C; Simpson EM; Friedman JM; van Karnebeek C; Leavitt BR
    Hum Mol Genet; 2020 Nov; 29(19):3266-3284. PubMed ID: 32969477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyridoxine-dependent epilepsy owing to antiquitin deficiency--mutation in the ALDH7A1 gene.
    Jagadeesh S; Suresh B; Murugan V; Suresh S; Salomans GS; Struys EA; Jacobs C
    Paediatr Int Child Health; 2013 May; 33(2):113-5. PubMed ID: 23925287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human pyrroline-5-carboxylate reductase (PYCR1) acts on Δ(1)-piperideine-6-carboxylate generating L-pipecolic acid.
    Struys EA; Jansen EE; Salomons GS
    J Inherit Metab Dis; 2014 May; 37(3):327-32. PubMed ID: 24431009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel therapy for pyridoxine dependent epilepsy due to ALDH7A1 genetic defect: L-arginine supplementation alternative to lysine-restricted diet.
    Mercimek-Mahmutoglu S; Cordeiro D; Cruz V; Hyland K; Struys EA; Kyriakopoulou L; Mamak E
    Eur J Paediatr Neurol; 2014 Nov; 18(6):741-6. PubMed ID: 25127453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy.
    Engelke UF; van Outersterp RE; Merx J; van Geenen FA; van Rooij A; Berden G; Huigen MC; Kluijtmans LA; Peters TM; Al-Shekaili HH; Leavitt BR; de Vrieze E; Broekman S; van Wijk E; Tseng LA; Kulkarni P; Rutjes FP; Mecinović J; Struys EA; Jansen LA; Gospe SM; Mercimek-Andrews S; Hyland K; Willemsen MA; Bok LA; van Karnebeek CD; Wevers RA; Boltje TJ; Oomens J; Martens J; Coene KL
    J Clin Invest; 2021 Aug; 131(15):. PubMed ID: 34138754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An intriguing "silent" mutation and a founder effect in antiquitin (ALDH7A1).
    Salomons GS; Bok LA; Struys EA; Pope LL; Darmin PS; Mills PB; Clayton PT; Willemsen MA; Jakobs C
    Ann Neurol; 2007 Oct; 62(4):414-8. PubMed ID: 17721876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delta-1-piperideine-6-carboxylate dehydrogenase, a new enzyme that forms alpha-aminoadipate in Streptomyces clavuligerus and other cephamycin C-producing actinomycetes.
    de La Fuente JL; Rumbero A; Martín JF; Liras P
    Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):59-64. PubMed ID: 9355735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the first knock-out aldh7a1 zebrafish model for pyridoxine-dependent epilepsy using CRISPR-Cas9 technology.
    Zabinyakov N; Bullivant G; Cao F; Fernandez Ojeda M; Jia ZP; Wen XY; Dowling JJ; Salomons GS; Mercimek-Andrews S
    PLoS One; 2017; 12(10):e0186645. PubMed ID: 29053735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolite Identification Using Infrared Ion Spectroscopy─Novel Biomarkers for Pyridoxine-Dependent Epilepsy.
    van Outersterp RE; Engelke UFH; Merx J; Berden G; Paul M; Thomulka T; Berkessel A; Huigen MCDG; Kluijtmans LAJ; Mecinović J; Rutjes FPJT; van Karnebeek CDM; Wevers RA; Boltje TJ; Coene KLM; Martens J; Oomens J
    Anal Chem; 2021 Nov; 93(46):15340-15348. PubMed ID: 34756024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyridoxine-dependent seizures in Dutch patients: diagnosis by elevated urinary alpha-aminoadipic semialdehyde levels.
    Bok LA; Struys E; Willemsen MA; Been JV; Jakobs C
    Arch Dis Child; 2007 Aug; 92(8):687-9. PubMed ID: 17088338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyridoxine-dependent epilepsy due to antiquitin deficiency: achieving a favourable outcome.
    Oliveira R; Pereira C; Rodrigues F; Alfaite C; Garcia P; Robalo C; Fineza I; Gonçalves O; Struys E; Salomons G; Jakobs C; Diogo L
    Epileptic Disord; 2013 Dec; 15(4):400-6. PubMed ID: 24184718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy.
    Al Teneiji A; Bruun TU; Cordeiro D; Patel J; Inbar-Feigenberg M; Weiss S; Struys E; Mercimek-Mahmutoglu S
    Metab Brain Dis; 2017 Apr; 32(2):443-451. PubMed ID: 27882480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Prospective Case Study of the Safety and Efficacy of Lysine-Restricted Diet and Arginine Supplementation Therapy in a Patient With Pyridoxine-Dependent Epilepsy Caused by Mutations in ALDH7A1.
    Mahajnah M; Corderio D; Austin V; Herd S; Mutch C; Carter M; Struys E; Mercimek-Mahmutoglu S
    Pediatr Neurol; 2016 Jul; 60():60-5. PubMed ID: 27212567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary AASA excretion is elevated in patients with molybdenum cofactor deficiency and isolated sulphite oxidase deficiency.
    Mills PB; Footitt EJ; Ceyhan S; Waters PJ; Jakobs C; Clayton PT; Struys EA
    J Inherit Metab Dis; 2012 Nov; 35(6):1031-6. PubMed ID: 22403017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzymes responsible for the conversion of N alpha-[(Benzyloxy)carbonyl]-D-lysine to N alpha-[(Benzyloxy)carbonyl]-D-aminoadipic acid by Rhodococcus sp. AIU Z-35-1.
    Isobe K; Fukuda N; Nagasawa S; Saitou K
    Chem Biodivers; 2010 Jun; 7(6):1549-54. PubMed ID: 20564569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification and characterization of a dehydrogenase catalyzing conversion of N alpha-benzyloxycarbonyl-L-aminoadipic-delta-semialdehyde to N alpha-benzyloxycarbonyl-L-aminoadipic acid from rhodococcus sp. AIU Z-35-1.
    Isobe K; Fukuda N; Nagasawa S
    J Biosci Bioeng; 2007 Nov; 104(5):398-402. PubMed ID: 18086440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.